New and Comprehensive Protein Dataset Elevates Health Research
A new study utilizing data from over 54,000 UK Biobank participants has been published in Nature. Conducted by the Pharma Proteomics Project – a collaboration of 13 leading biopharmaceutical companies – it is the largest body of work analyzing the effects of common gene variations on blood proteins, and how these may contribute to disease, to date.
Technology Networks had the pleasure of speaking with Dr. Chris Whelan, director of Neuroscience, Data Science and Digital Health at Janssen Research & Development and leader of the Pharma Proteomics Project. In this conversation, Whelan explains how the research team were able to capture data on difficult-to-reach proteins, why we
must look beyond genomics data alone in drug development and how he envisions
this comprehensive dataset will be utilized.
